Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hyperthyroidism

Verfasser / Beitragende:
[Cihangir Erem, Ozge Ucuncu, Mustafa Yilmaz, Mustafa Kocak, İrfan Nuhoglu, Halil Ersoz]
Ort, Verlag, Jahr:
2009
Enthalten in:
Endocrine, 36/3(2009-12-01), 473-478
Format:
Artikel (online)
ID: 453622992